An Immunologist Challenges the Status Quo

The diabetes drugs that transformed weight loss may be key to treating addiction, too. Dr. Sanjay Gupta speaks with Dr. Dhruv Khullar about how GLP-1s affect the brain, its reward system, and maybe even addiction. This episode was produced by Jennifer Lai with assistance from Sof ...  Show more

An FDA panel has recommended allowing compounding pharmacies to make six unapproved peptides. Dr. Sanjay Gupta and CNN Health's John Bonifield discuss their popularity, safety concerns and what comes next. This episode was produced by Madeleine Thompson and Leying Tang. Medical W ...  Show more

Dr. Francis Collins talks with health correspondent Selena Simmons-Duffin about Americans' overall health, how tribalism in American culture has fueled vaccine hesitancy, and advises his successor on how to persevere on research of politically charged topics — like guns and obesi ...  Show more

In this episode, Maddie Sofia talks with Invisibilia's Alix Spiegel about the bioethics of conducting human challenge trials with the aim of producing a viable coronavirus vaccine. We hear from James Kublin, a clinical health professor in the Department of Global Health at the Un ...  Show more

Mati Hlatshwayo Davis, MD, MPH and Tina Tan, MD, FIDSA discuss the impact COVID-19 has had on maternal mortality, the downstream effects from unequal access to care and how providers can advocate for health equity. 

In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ...  Show more